Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.8K
Overview
51.8K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.

Annals of the rheumatic diseases·2022
Same author

Identification of neuroblastoma cell lines with uncommon TAZ<sup>+</sup>/mesenchymal stromal cell phenotype with strong suppressive activity on natural killer cells.

Journal for immunotherapy of cancer·2021
Same author

Wilms' Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and Macrophages.

Cancers·2021
Same author

Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors.

Cancer immunology research·2020
Same author

Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: Review of Current Status.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2019
Same author

The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors.

Oncotarget·2019
Same journal

Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

Nature medicine·2026
Same journal

Data rights are the missing pillar for modernizing consent in medicine.

Nature medicine·2026
Same journal

Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

Nature medicine·2026
Same journal

Immune aging biomarkers for clinical trials.

Nature medicine·2026
Same journal

Lassa fever countermeasures gather pace.

Nature medicine·2026
Same journal

Why high scores do not mean application readiness for health AI.

Nature medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 9, 2026

Vaccines, APCs and Memory Cells
01:51

Vaccines, APCs and Memory Cells

51.8K

Mesenchymal stem cells combat sepsis

Alan Tyndall, Vito Pistoia

    Nature Medicine
    |January 9, 2009
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Cancer Vaccines
    01:30

    Cancer Vaccines

    1.1K

    Related Experiment Videos

    Last Updated: Feb 9, 2026

    Vaccines, APCs and Memory Cells
    01:51

    Vaccines, APCs and Memory Cells

    51.8K
    Cancer Vaccines
    01:30

    Cancer Vaccines

    1.1K